central corneal endothelial cell density and central corneal thickness in ocular hypertension and...
TRANSCRIPT
CENTRAL CORNEAL ENDOTHELIAL CELL DENSITY AND CENTRALCORNEAL THICKNESS IN OCULAR HYPERTENSION AND PRIMARY
OPEN-ANGLE GLAUCOMA
MICHAEL KOREY, M.D., DAVID GIESER, M.D., MICHAEL A. Kxss, M.D.,STEPHEN R. WALTMAN, M.D., MAE GORDON, PH.D.,
AND BERNARD BECKER, M.D.St. Louis, Missouri
In order to assess the effect of increased intraocular pressure on thecorneal endothelium, we classified 254 patients into four groups: Group1, those with normal intraocular pressures; Group 2, those withuntreated ocular hypertension; Group 3, those with treated ocularhypertension; and Group 4, those with primary open-angle glaucoma.One eye of each patient underwent specular microscopy and pachymetry. The eyes in the four groups did not differ significantly as to centralcorneal endothelial cell density or central corneal thickness. Thesemeasurements were not related to sex, race, or intraocular pressure (P> .12 in all cases). Increasing age was associated with a decrease incentral corneal endothelial cell density (P = .0(01), but was notassociated with a change in central corneal thickness (P = .22). Therewas no significant relationship between the use of topical ocularhypotensive medications and central corneal endothelial cell density (P= .38) or central corneal thickness (P = .07) in patients with ocularhypertension or primary open-angle glaucoma. Neither uncomplicatedperipheral iridectomy nor trabeculectomy produced significant changeswhen preoperative measurements were compared to measurementsmade 12 weeks postoperatively (P > .30 in all cases). Two eyes with flatanterior chambers following trabeculectomy had substantial decreasesin central corneal endothelial cell density.
There is evidence suggesting that increased intraocular pressure and medicaland surgical treatment of glaucoma canaffect the structure and function of thecorneal endothelium. Corneal edema oc-
Accepted for publication Aug. 13, 1982.From the Department of Ophthalmology, Wash
ington University School of Medicine, St. Louis,Missouri. This study was supported in part by grantEY 00004 from the National Eye Institute and by anunrestricted grant from Research to Prevent Blindness, Inc., New York, New York.
Reprint requests to Michael A. Kass, M.D., Department of Ophthalmology, Washington UniversitySchool of Medicine, 660 S. Euclid Ave., St. Louis,MO 63110.
curs in some eyes with glaucoma, particularly in eyes that experience a rapid andmarked increase in intraocular pressure.Decreased central corneal endothelialcell density occurs in eyes with acuteangle-closure glaucoma.P glaucomatocyclitic crisis," and glaucoma capsulare."Experimentally induced ocular hypertension produces morphologic changes inrabbit! and monkey'' corneal endotheliumthat may be associated with decreasedcorneal clarity and increased central corneal thlckness.F' Topical or intracameraladministration of ocular hypotensivemedications and their preservatives candamage the corneal endothelium in
610 ©AMERICAN JOURNAL OF OPHTHALMOLOGY 94:610-616, 1982
VOL. 94, NO.5 CORNEAL ENDOTHELIUM 611
human and animal eyes.r" Peripheral iridectomy and trabeculectomy can producea decrease in central corneal endothelialcell density. 1 Although these reports suggest that increased intraocular pressureand antiglaucoma treatment can have adverse effects on the corneal endothelium,there are no published studies evaluatingthese matters systematically.
Specular mieroscopy'<P and pachymetry" allow in vivo examination of corneal endothelial morphology and function. Our purpose was to use thesetechniques to determine whether increased intraocular pressure, primaryopen-angle glaucoma, and medical andsurgical glaucoma therapy affect centralcorneal endothelial cell density and central corneal thickness.
SUBJECTS AND METHODSA total of 254 patients participated in
this study after giving informed consents.If both eyes of a patient were eligible forinclusion in the study, we randomlychose one eye. All subjects had at leastthree intraocular pressure measurementswith a minimum follow-up period of sixmonths (range, six to 278 months).
We divided the 254 patients into fourgroups (Table 1). Group I-We classified103 patients as having normal intraocularpressures on the basis of normal visualfields, normal optic disks, and intraocularpressure readings of::5 20 mm Hg. Group2-We classified 62 patients as havingocular hypertension on the basis of threeor more intraocular pressure measurements of 21 mm Hg or higher, normal
TABLE 1
CLINICAL FINDINGS
Group 1· Group 2· Group 3· Group 4·Clinical Findings (No. = 103) (No. = 62) (No. = 35) (No. = 54)
Age (yrs)Mean ± S.D. 54.5 ± 13.4 57.3 ± 10.3 58.9 ± 12.8 64.5 ± 10.6Range 22 to 78 29 to 74 27 to 79 30 to 80
SexMale 44 (42.7%) 35 (56.4%) 16 (45.7%) 23 (42.6%)Female 59 (57.3%) 27 (43.6%) 19 (54.3%) 31 (57.4%)
RaceWhite 95 (92.7%) 55 (88.7%) 23 (65.7%) 24 (44.4%)Black 8 (7.8%) 7 (11.3%) 12 (34.3%) 30 (55.6%)
Duration of disease (mos)Mean ± S.D. 129.2 ± 71.1 121.4 ± 71.2 64.6 ± 40.6Range 6 to 272 21 to 278 6 to 158
Intraocular pressure (mm Hg)At time of pachymetry
Mean ± S.D. 17.0 ± 2.7 23.8 ± 3.5 22.6 ± 3.9 20.3 ± 4.7Range 11 to 20 14 to 31 15 to 32 12 to 32
During follow-upMean ± S.D. 16.0 ± 2.0 22.4 ± 2.3 24.1 ± 3.6 22.6 ± 3.3Range 11 to 20 18 to 28 18 to 32 15 to 31
Central corneal endothelial celldensity (cells/mm')Mean ± S.D. 2,117.4 ± 373.2 2,164.4 ± 330.6 2,120.5 ± 291.8 2,079.0 ± 270.6Range 1,345 to 3,508 1,591 to 3,152 1,506 to 2,270 1,424 to 2,769
Central corneal thickness (mrn)Mean ± S.D. 0.52 ± 0.02 0.52 ± 0.01 0.52 ± 0.04 0.51 ± 0.02Range 0.44 to 0.61 0.47 to 0.56 0.45 to 0.67 0.46 to 0.61
"Croup 1, normal; Group 2, untreated ocular hypertension; Group 3, treated ocular hypertension; Group 4,primary open-angle glaucoma.
612 AMERICAN JOURNAL OF OPHTHALMOLOGY NOVEMBER, 1982
OCULAR HYPOTENSIVE MEDICATIONS
TABLE 2
*Some patients received more than one medication.
optic disks, and normal visual fields. Themean intraocular pressure for a givenpatient included all values recorded during follow-up for that individual. Thesepatients had not used ocular hypotensivemedication at any time. Group 3-Another 35 patients with ocular hypertension (classified by the same criteria asGroup 2) had received topical ocular hypotensive medication. Table 2 shows thedrugs used and the duration of therapy.The mean intraocular pressure record fora subject who had received ocular hypotensive therapy included both treatedand untreated measurements in order toreflect the intraocular pressures to whichthe cornea had been exposed over a period of time. Group 4-We classified 54patients as having primary open-angleglaucoma on the basis of mean untreatedintraocular pressures of 21 mm Hg orhigher, open angles on gonioscopy, andtypical glaucomatous optic disk cuppingand visual field loss. Table 2 showsthe topical ocular hypotensive agentsused and the duration of therapy. Themean intraocular pressure for a givenpatient included both treated and untreated measurements during the followup period.
We also studied 23 patients scheduled
for glaucoma surgery prospectively. Seventeen patients (18 eyes) had uncontrolled open-angle glaucoma (14 primaryopen-angle glaucoma, two pigmentaryglaucoma, and one posttraumatic anglerecession) necessitating filtering surgery.Excisional trabeculectomies were performed anterior to the scleral spur. Sixpatients (eight eyes) scheduled for peripheral iridectomy were also studiedprospectively. Seven eyes underwentsurgical iridectomy for chronic angleclosure glaucoma and one eye had a prophylactic iridectomy.
We excluded all eyes with a history orfindings of previous corneal disease, ocular inflammation, ocular trauma, or ocularsurgery. (The exclusion criteria of previous ocular surgery or ocular trauma didnot apply to eyes undergoing trabeculectomy.) Eyes undergoing iridectomy wereexcluded from the study if there wasevidence of previous attacks of acuteangle-closure glaucoma, including glaucomflecken, sector iris atrophy, peripheral anterior synechiae, and posteriorsynechiae.
Central corneal thickness was measured in a masked fashion with a pachymeter mounted on a slit lamp as described by Mishima and Hedbys." Threemeasurements of central corneal thickness were obtained, recorded to the nearest 0.01 rnm, and averaged.
Specular microscopy was performed bythe method of Waltman and associates."Five photographs were taken of the central corneal endothelium before any procedure that might affect corneal clarity.The photographs were analyzed in amasked fashion with a rho-theta plottingdevice interfaced to a minicomputer viaan analog-to-digital converter. Twenty to50 cells were traced on each photograph.The total area of the cells traced wascalculated to yield a mean cell area whichwas converted to a mean endothelial celldensity per square millimeter.
32.8 ± 27.614.9 ± 23.418.6 ± 32.7
2.0 ± 0.042.1 ± 36.410.8 ± 9.410.4 ± 8.919.5 ± 19.014.2 ± 15.5
Duration ofTherapy (mos)(Mean ± S.D.)
No. ofMedication Patients*
Pilocarpine 62Carbachol 22Echothiophate iodide 14Demecarium bromide 2Epinephrine 73Dipivefrin 16Timolol 59Acetazolamide 29Methazolamide 25
VOL. 94, NO. 5 CORNEAL ENDOTHELIUM 613
Central corneal endothelial cell densityand central corneal thickness were measured in all patients. Additionally, patients undergoing glaucoma surgery hadpachymetry and specular microscopyperformed before surgery and again 12weeks postoperatively.
We conducted a test-retest reliabilitystudy to evaluate how much of the variability in central corneal endothelial celldensity between individuals was the result of measurement variability. Each eyeof 22 normal volunteers was photographed in two sessions. The technicianperformed the cell counts in a maskedfashion. Test-retest reliability was estimated with an intraclass correlation coefficient in which variability resulting fromphotography, technician, and the interaction of these sources with the subjectwere included in the error term. Theintraclass correlation was .93, suggestingthat the variability observed between individuals was not affected substantially bymeasurement variability. The mean percentage difference between the centralcorneal endothelial cell densities recorded at the first and the second sessions forthe same eye was 5.6% ± 5.4% (range,0.2% to 19.7%). The difference betweenthe two measurements was more than10% in seven of 44 eyes (15%).
RESULTS
Neither mean central corneal endothelial cell density nor central corneal thickness differed significantly among the fourgroups (Table 1). We evaluated the effectsof age, sex, race, and intraocular pressurein each group and in the combined sample with a linear regression model. Theinfluence of each factor was consideredalone as well as in combination with theother factors. Increasing age was associated with a decrease in central cornealendothelial cell density (r = -.31; P =.0001) but was not associated with a
change in central corneal thickness (P =.22). Sex, race, and intraocular pressures(both mean values and those obtained onthe day of pachymetry and specular microscopy) were not related significantly tocentral corneal endothelial cell density(P > .12 in all cases) or to central cornealthickness (P > .28 in all cases).
To further assess the effect of intraocular pressure, we compared Group 1 toGroup 2. There was no substantial difference between the two groups with respect to central corneal endothelial celldensity (P = .10) or central corneal thickness (P = .69) after controlling for theeffects of age.
Group 1 and Group 4 did not differwith respect to central corneal endothelial cell density (P = .53) or central cornealthickness (P = .19) after controlling forthe effects of age.
We assessed the possible effect of topical ocular hypotensive medication in twoways. (1) We compared Group 2 to Group3. After controlling for the effects of age,there was no significant difference between the two groups with respect tocentral corneal endothelial cell density(P = .38) or central corneal thickness(P = .07). (2) The effect of the duration oftopical ocular hypotensive medicationwas evaluated in Groups 3 and 4. Duration of antiglaucoma therapy was not related to central corneal endothelial celldensity (P = .33) or central corneal thickness (P = .18). Because most patients hadreceived several medications, it was notpossible to determine the effect of anindividual drug or an individual preservative.
Neither trabeculectomy nor peripheraliridectomy produced significant changesin central corneal endothelial cell density(P > .29 in both cases) or central cornealthickness (P > .40 in both cases) whenpreoperative measurements were compared to those made 12 weeks postoperatively (Table 3). Three eyes had shallow
614 AMERICAN JOURNAL OF OPHTHALMOLOGY NOVEMBER, 1982
TABLE 3
EFFECT OF SURGERY
Clinical Trabecu-Findings lectomy Iridectomy
No. of patients 17 6No. of eyes 18 8Age (yrs)
Mean ± S.D. 61 ± 12.1 66.6 ± 8.4Range 38 to 81 57 to 76
SexMale 13 (76.5%) 1 (16.7%)Female 4 (23.5%) 5 (83.3%)
RaceWhite 10 (58.8%) 5 (83.3%)Black 7 (41.2%) 1 (16.7%)
Central cornealendothelialcell density(cells/mm')Preoperative
Mean ± S.D. 2,004 ± 465.8 2,066 ± 178.5Range 826 to 2,613 1,722 ± 2,350
PostoperativeMean ± S.D. 1,941 ± 522.4 2,127 ± 216.0Range 833 to 2,626 1,782 to 2,489
Central cornealthickness (mm)Preoperative
Mean ± S.D. 0.53 ± 0.03 0.53 ± 0.02Range 0.47 to 0.59 0.49 to 0.56
PostoperativeMean ± S.D. 0.52 ± 0.03 0.51 ± 0.02Range 0.47 to 0.56 0.49 to 0.53
anterior chambers after trabeculectomyand two developed substantial decreasesin central corneal endothelial cell density. One eye with a flat anterior chamberthat required drainage of suprachoroidalfluid and re-formation of the chamber onthe fifth postoperative day had a decreaseof 497 cells/mm'', Another eye with ashallow anterior chamber from a leakingconjunctival wound that was resutured onthe third postoperative day had a decrease of 597 cells/mm'',
DISCUSSION
Most of the eyes with ocular hypertension or primary open-angle glaucoma hadintraocular pressures between 20 and26 mm Hg (range, 15 to 32 mm Hg) and
normal central corneal endothelial celldensities. Bigar" noted normal centralcorneal endothelial cell densities in 12patients with open-angle glaucoma.Thus, modest increases in intraocularpressure, even for prolonged periods,seem to have little effect on the cornealendothelium. (This study provided nodata on the effect of severely increasedintraocular pressure.) Decreased centralcorneal endothelial cell densities havebeen reported in eyes with acute angleclosure glaucorna-v" and glaucomatocyclitic cnsts." Both of these diseases arecharacterized by sudden and marked increases in intraocular pressure and areassociated with anterior segment inflammation. Animal studies indicate that increases in intraocular pressure to 33 to70 mm Hg are necessary to produce morphologic evidence of endothelial damage. 5,6
Vannas, Setala, and Ruusuvaara' reported a small decrease in central cornealendothelial cell density in the affectedeyes of patients with unilateral glaucomacapsulare. Although they contended thatthe decrease was the result of increasedintraocular pressure, they did not reportthe intraocular pressure differential between the affected and the unaffectedeyes. Furthermore, the difference in density between the two eyes was not relatedto the intraocular pressure or the duration of the disease. Only eight of 27patients (29.6%) had a difference in central corneal endothelial cell density between the two eyes of more than 5%. Thedecrease in density reported by Vannas,Setala, and Buusuvaara' seems to havelittle clinical significance and supportsour contention that modest increases inintraocular pressure have little effect.
Some authorities consider a history ofglaucoma to be a contraindication to theuse of donor corneas for penetrating keratoplasty. This study suggests that mostcorneas from patients with ocular hyper-
VOL. 94, NO. 5 CORNEAL ENDOTHELIUM 615
tension or primary open-angle glaucomahave enough endothelial cells to serve asdonor material. Similarly, there is considerable debate about whether intraocular lenses should be implanted in eyeswith increased intraocular pressures. Although this is a complex decision thatmust be made on an individual basis foreach patient, this study indicated goodendothelial reserve in most eyes withocular hypertension or primary openangle glaucoma.
Topical or intracameral administrationof ocular hypotensive medications andtheir preservatives can damage cornealendothelium in human and animaleyes.8-10 Waltman and associates" found a6.2% decrease in central corneal endothelial cell density in a small group ofeyes with ocular hypertension treatedwith topical epinephrine hydrochloridecompared to untreated fellow eyes. Ourstudy found no association between ocular hypotensive medication and centralcorneal endothelial cell density. Becausemost patients had received several medications, it was not possible to determinethe effect of individual drugs or preservatives and, thus, a small effect of a givendrug may not have been detected. It isunlikely that a clinically important effectwas missed.
In the present study, uncomplicatedtrabeculectomy and iridectomy had littleeffect on central corneal endothelial celldensity. It is possible that greater lossesof endothelium occur at the site of surgery, as has been reported with cataractextraction" and intraocular lens implantation." However, since the incision inglaucoma surgery is relatively small, it isunlikely that such a discrepancy would beof importance. A flat anterior chamberfollowing trabeculectomy can cause amarked decrease in central corneal endothelial cell density. In one patient, thisoccurred even though surgical re-formation of the anterior chamber was not
required. Thus, it seems likely that theflat chamber itself, rather than the surgical re-formation, was the cause of theendothelial cell loss. The decrease incentral corneal endothelial cell densitysuggested that an anterior chamber thatis flat following filtering surgery shouldbe re-formed early. The endothelial cellloss may be the result of mechanicaleffects of the iris or lens on the endothelium, inflammation, altered aqueous humor metabolism, hypotony, or some combination of these factors.
In our small series, uncomplicated peripheral iridectomy produced no significant effect on central corneal endothelialcell density. Other studies have reporteddecreases of 4.8%1 and 1.3%2 as a resultof iridectomy. Acute attacks of angleclosure glaucoma have been reported tocause decreases of 9.7%,1 23.1%,2 and39%.15 The greater loss of endothelialcells after acute angle-closure glaucomasupports the practice of prophylactic iridectomy in eyes at substantial risk ofdeveloping this disease (that is, felloweyes of eyes that developed acute angleclosure glaucoma).
The reports on intraocular pressureand central corneal thickness are contradictory. Increased intraocular pressurehas been said to have no effect on centralcorneal thickness, 18 to increase it, 19 and todecrease it. 2,20-2'2 Many of these studies aredifficult to interpret because they wereperformed on eyes with secondary f&:-msof glaucoma,10,18,19 inflammation,IO,18,19,2'2 orextreme levels of intraocular pressure,2,10,18.20,21 or were performed on eyesrecovering from surgery.P' These findings suggest that increased intraocular pressure thins the cornea if the endothelium is functioning we1l2,20,21 but thatthis effect is of small magnitude. Ehlers"reported that decreasing intraocularpressure by 24 mm Hg with medicationincreases central corneal thickness byless than 0.02 mm. Olson and Kaufman'"
616 AMERICAN JOURNAL OF OPHTHALMOLOGY NOVEMBER, 1982
noted that intraocular pressure increasedby 18 mm Hg after combined cataractextraction-keratoplasty decreased centralcorneal thickness by 0.034 mm. In ourstudy, the difference in intraocular pressure among the groups was too small toproduce detectable changes in centralcorneal thickness. Once again, however,this suggested that the corneal endothelium functions well in most eyes with ocular hypertension or primary open-angleglaucoma.
REFERENCES
1. Setala, K.: Corneal endothelial cell densityafter an attack of acute glaucoma. Acta OphthalmoL57:1004, 1979.
2. Olsen, T.: The endothelial cell damage in acuteglaucoma. On the corneal thickness response tointraocular pressure. Acta Ophthalmol. 58:257, 1980.
3. Setala, K., and Vannas, A.: Endothelial cells inthe glaucomato-cyclitic crisis. Adv. OphthaimoL36:218, 1978.
4. Vannas, A., Setala, A., and Ruusuvaara, P.:Endothelial cells in capsular glaucoma. Acta Ophthalmol. 55:951, 1977.
5. Melamed, S., Ben-Sira, I., and Ben-Shaul, Y.:Corneal endothelial changes under induced intraocular pressure elevations. A scanning and transmissionelectron microscopic study in rabbits. Br. J. Ophthalmol. 64:164, 1980.
6. Svedbergh, B.: Effects of artificial intraocularpressure elevation on the corneal endothelium in thevervet monkey iCeriopithecus ethiops). Acta Ophthalmol. 53:839, 1975.
7. Ytteborg, J., and Dohlman, C.: Corneal edemaand intraocular pressure. 1. Animal experiments.Arch. Ophthalmol. 74:375, 1965.
8. Jay, J. L., and MacDonald, M.: Effects ofintraocular miotics on cultured bovine corneal endothelium. Br. J. Ophthalmol. 62:815, 1978.
9. Waltman, S. R., Yarian, D., Hart, W., [r., andBecker, B.: Corneal endothelial changes with longterm topical epinephrine therapy. Arch. Ophthalmol. 95:1357, 1977.
10. Gasset, A. R., Ishii, Y., Kaufman, H. E., andMiller, T.: Cytotoxicity of ophthalmic preservatives.Am. J. OphthalmoL 78:98, 1974.
ll. Maurice, D. M.: Cellular membrane activityin the corneal endothelium of the intact eye. Expertentia 24:1094, 1975.
12. Laing, R. A., Sandstrom, M. M., and Leibowitz, H. M.: In vivo photomicrography of thecorneal endothelium. Arch. Ophthalmol. 93:143,1975.
13. Bourne, W. M., and Kaufman, H. E.: Specular microscopy of human corneal endothelium invivo. Am. J. Ophthalmol, 81:319, 1976.
14. Mishima, S., and Hedbys, B. 0.: Measurement of corneal thickness with the Haag-Streit pachometer. Arch. OphthalmoL 80:710, 1968.
15. Bigar, F.: Specular microscopy of the cornealendothelium. Optical solutions and clinical results.Rev. Ophthalmol. 6:1, 1982.
16. Hoffer, K. J.: Vertical endothelial cell disparity. Am. J. Ophthalmol. 87:344, 1979.
17. Blackwell, W. L., Gravenstein, N., and Kaufman, H. E.: Comparison of central corneal endothelial cell numbers with peripheral areas. Am. J.Ophthalmol, 84:473, 1977.
18. Ytteborg, J., and Dohlman, C. H.: Cornealoedema and intraocular pressure. II. Clinical results.Arch. OphthalmoL 74:477, 1965.
19. DeCevallos, A., Dohlman, C. H., and Reinhart, W. J.: Corneal thickness in glaucoma. Ann.Ophthalmol. 8:177, 1976.
20. Olson, R. J., and Kaufman, H. E.: Intraocularpressure and corneal thickness after penetrating keratoplasty. Am. J. OphthalmoL 86:97, 1978.
21. Ehlers, N.: On corneal thickness and intraocular pressure. II. A clinical study on the thickness ofthe corneal stroma in glaucomatous eyes. Acta OphthalmoL 48:1107, 1970.
22. Ehlers, N., and Riise, D.: On corneal thickness and intraocular pressure. A clinical study of thethickness of the cornea in eyes with retinal detachment. Acta Ophthalmol. 45:809, 1967.